Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease.
about
Huntingtin in health and diseaseNeuroprotective effects of inositol 1,4,5-trisphosphate receptor C-terminal fragment in a Huntington's disease mouse modelIron dysregulation in Huntington's diseaseGenetics and neuropathology of Huntington's diseaseMaintenance of basal levels of autophagy in Huntington's disease mouse models displaying metabolic dysfunctionHuntingtin and its role in neuronal degenerationCellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic miceEvent time analysis of longitudinal neuroimage data.Functional imaging in Huntington's disease.Dopamine D2 receptor stimulation potentiates PolyQ-Huntingtin-induced mouse striatal neuron dysfunctions via Rho/ROCK-II activationMitochondrial matters of the brain: the role in Huntington's disease.Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's diseasePathophysiology of secondary depressions in the elderly.In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects.Somatostatin receptor 1 and 5 double knockout mice mimic neurochemical changes of Huntington's disease transgenic miceChronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates.The selective vulnerability of nerve cells in Huntington's disease.Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease.Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis.Neuroprotective possibilities for Huntington's disease.Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's diseaseIs a motor criterion essential for the diagnosis of clinical huntington disease?Activated microglia proliferate at neurites of mutant huntingtin-expressing neuronsThe role for alterations in neuronal activity in the pathogenesis of polyglutamine repeat disorders.Motor impairments, striatal degeneration, and altered dopamine-glutamate interplay in mice lacking PSD-95Differential localization of the GluR1 and GluR2 subunits of the AMPA-type glutamate receptor among striatal neuron types in rats.Effect of latent iron deficiency on GABA and glutamate neuroreceptors in rat brain.Increased Expression of Osteopontin in the Degenerating Striatum of Rats Treated with Mitochondrial Toxin 3-Nitropropionic Acid: A Light and Electron Microscopy Study.Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington's disease.Molecular mechanisms and potential therapeutical targets in Huntington's disease.The clinical and genetic features of Huntington disease.Ginsenosides and their CNS targets.Huntington's disease and Group I metabotropic glutamate receptors.Brain networks in Huntington disease.Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease.Strategies for regenerating striatal neurons in the adult brain by using endogenous neural stem cellsPathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development.Reassessing models of basal ganglia function and dysfunction.The role of the human globus pallidus in Huntington's disease.
P2860
Q24554374-12ADE0C6-E103-46E2-91EA-C1A132D19A48Q24647950-33074D24-FED9-431A-82D7-223560A89A29Q26829932-2D4E4ABB-F39D-481C-885B-773A275426D2Q27023050-F30A1FC6-6C4C-4F99-99CD-DCB28343558CQ27341821-8FE60B96-8713-48FB-8372-0F51942D5BE2Q28281434-FD0B5B32-61A3-4C69-B683-D9303FBA11DDQ28510296-24BC6D5B-7043-4989-AB00-EA2ECA5C8123Q30801659-874A0C0F-F088-44FA-A493-28C566A90DDAQ33403110-75834FAE-FEF7-4407-A5A5-D896BB4C57F8Q33519066-C36E796D-0489-4723-8A2E-6549004F3CCEQ33580327-2394660E-56F8-42D7-B79A-A223B652CAA1Q33703899-706EB715-587E-40AE-B5BB-7E89301951E0Q33792252-DE431C72-5FEE-48EB-84B8-FA703177EBA8Q33980357-767C3000-4920-411A-B532-97392162BEEDQ34017941-F54A1A67-DC78-4886-ADEC-0A9A4B7CE7DBQ34103541-435B6007-E89F-49F8-A73C-91693789C845Q34216757-DF9988DE-BB67-4749-A23C-805EE267F8B3Q34273178-FFA32996-74BE-445A-A6D0-77FB4FC71DF3Q34320446-3A6389DF-3008-4915-9DED-7066AF31871BQ34451995-0011BBBF-48D3-44E6-8B0B-5D8F7311FA1DQ34695123-154B222F-6C18-4C2B-8FB0-45628A7276DAQ34709693-DED62C71-A152-434A-BFC3-232595565B17Q35103285-F22615E5-2A8E-4020-93D1-0DB0A040E19DQ35340099-5DCFF5A8-85A5-450D-B4FC-4C20AE8141F3Q35526468-EFABC60A-8F60-4F05-A13F-0B38F110A3ACQ36012795-50D47080-2210-4F69-8406-407E77AB31D3Q36264549-5FC7CE8C-7F5A-46C4-A80D-2BA459BBF298Q36297458-AD3BB085-202A-4699-AE6A-EB7056915B81Q36348804-E92194F3-7A21-4315-A0EE-11F6A21DC7CEQ37776087-AE1462D8-086D-4DC9-9C10-36E680C38BFCQ37798079-1CA6F108-5B9C-4976-8923-FE3C1B943BD1Q37818509-F4FAFEB2-B390-4D22-A944-3F5126F711A6Q37820343-EFA7193B-35D2-4B08-B9EB-A52113A1DE86Q37834193-AADD2CB0-1373-466A-9500-9FD7472110AAQ37839534-7206EE35-95A5-4C97-B066-C00E2D3F1AC1Q37902080-89E21676-4E88-4FE0-A824-51754BB09B6DQ37930190-9F31E9F3-4FE2-40BB-B0C5-C35F3E329549Q37947984-FFF8554A-38A0-4128-9814-F737A061D5BCQ38230498-3D3E039B-11B2-438D-AB99-57EF66C7BF1AQ38928744-FECF530D-4DC9-465D-B2FB-41CA241319AB
P2860
Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Abnormalities of striatal proj ...... ptomatic Huntington's disease.
@en
Abnormalities of striatal proj ...... ptomatic Huntington's disease.
@nl
type
label
Abnormalities of striatal proj ...... ptomatic Huntington's disease.
@en
Abnormalities of striatal proj ...... ptomatic Huntington's disease.
@nl
prefLabel
Abnormalities of striatal proj ...... ptomatic Huntington's disease.
@en
Abnormalities of striatal proj ...... ptomatic Huntington's disease.
@nl
P2093
P1476
Abnormalities of striatal proj ...... ptomatic Huntington's disease.
@en
P2093
B Handelin
D S Markel
J B Penney
K D Anderson
W W Tourtellotte
P304
P356
10.1056/NEJM199005033221807
P407
P577
1990-05-01T00:00:00Z